OPERATING SYSTEM FOR PERSONALIZED MEDICINE
Live / Applied — New application — assigned to an examiner (as of 09 Sept 2026)
What this means for you
Not registered yet, but its 06 May 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99806960
- Mark type
- Stylized text
- Filed
- 06 May 2026
- Attorney of record
- David S Kerr
Goods and services
- Class 042 — Scientific and technological services: Software as a service (SAAS) services featuring software for generating, curating, and summarizing patient-specific target and variant intelligence for personalized therapy design, and automating literature review and report generation for patient cases in the field of drug development, custom drug development, and personalized anti-sense RNA drug development; Software as a service (SAAS) services featuring software for using artificial intelligence (AI) for drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for managing laboratory workflows and inventory, and managing patient intake and case files in the field of drug development, custom drug development, and personalized anti-sense RNA drug development; Platform as a service (PAAS) featuring computer software platforms for electronic storage, version control, and indexing of protocols, results, and case documentation and analytics in the field of drug development, custom drug development, and personalized anti-sense RNA drug development, all of the foregoing using artificial intelligence (AI)
Owner
- Nome Therapeutics, Inc., Chicago, IL, US
Prior registrations
Prosecution history
- 09 Sept 2026 — ASSIGNED TO EXAMINER
- 04 Sept 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 May 2026 — APPLICATION FILING RECEIPT MAILED
- 06 May 2026 — NEW APPLICATION ENTERED